Fronto-striatal damage may contribute to resistance to fatigue-lowering medications in multiple sclerosis.

Miklos PalotaiDiana PintyeBonnie GlanzTanuja ChitinisCharles R G Guttmann

Published in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2023)

Fronto-striatal damage may play a role in the development of resistance to fatigue-lowering treatment. Fronto-striatal FA may serve as a biomarker to predict response to fatigue-lowering medications in MS.

Keyphrases

multiple sclerosis
parkinson disease
functional connectivity
sleep quality
oxidative stress
mass spectrometry
ms ms
white matter
deep brain stimulation
depressive symptoms